Trastuzumab
A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.
Year introduced: 2016 (1998)
PubMed search builder options
Subheadings:
Tree Number(s): D12.776.124.486.485.114.224.060.875, D12.776.124.790.651.114.224.060.875, D12.776.377.715.548.114.224.200.875
MeSH Unique ID: D000068878
Registry Number: P188ANX8CK
Entry Terms:
- Trastuzumab beta
- beta, Trastuzumab
- Herceptin
- Trazimera
- Trastuzumab-qyyp
- Trastuzumab qyyp
See Also:
Pharmacologic Action: